1-(3-Nitropyridin-2-yl)piperidin-4-aminehydrochloride, 95.0%, 1g

6-propylpyrimidin-4-ol, 95.0%, 250mg

Oxazolo[5,4-b]pyridin-2-amine, 95.0%, 100mg

5-CHLORO-7-METHYL-1H-PYRROLO[3,2-B]PYRIDINE, 95.0%, 250mg

1-([1,2,4]triazolo[4,3-a]pyridin-8-yl)ethanamine, 98%, 1g

6,7-Difluoro-3,4-dihydro-2H-quinoxaline-1-carboxylic acid tert-butyl ester, 96%, 250mg

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97% 99%ee, 500mg

4-Methylbenzenesulfinamide, 95%, 25g

4-imino-3-(4-methylphenyl)-1,2,3,4-tetrahydroquinazolin-2-one, 95.0%, 250mg

Volumetric flasks with glass stopper, class A Brown glass, 100 ml, 14/23, 2 Piece(s)

2,4'-Dihydroxybenzophenone>98.0%(GC)5g

(E)-Pent-3-en-2-one, 98%, 100mg

Ethyl methyl carbonate, 97.0%, 25g